Contact
Please use this form to send email to PR contact of this press release:
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
TO:
Please use this form to send email to PR contact of this press release:
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
TO: